Oral administration of lithium carbonate to fed-healthy rats strongly decre
ased liver glycogen content, despite the simultaneous activation of glycoge
n synthase and the inactivation of glycogen phosphorylase. The effect seeme
d to be related to a decrease in glucose g-phosphate concentration and to a
decrease in glucokinase activity. Moreover, in these animals lithium marke
dly decreased liver fructose 2,6-bisphosphate, which could be a consequence
of the fall in glucose g-phosphate and of the inactivation of 6-phosphofru
cto-2-kinase. Liver pyruvate kinase activity and blood insulin also decreas
ed after lithium administration. Lower doses of lithium carbonate had less
intense effects. Lithium administration to starved-healthy and fed-streptoz
otocin-diabetic rats caused a slight increase in blood insulin, which was s
imultaneous with increases in liver glycogen, glucose 6-phosphate, and fruc
tose 2,6-phosphate. Glucokinase; 6-phosphofructo-2-kinase, and pyruvate kin
ase activities also increased after lithium administration int starved-heal
thy and fed-diabetic rats. Lithium treatment activated glycogen synthase an
d inactivated glycogen phosphorylase in a manner similar to that observed i
n fed-healthy rats. Glycemia was not modified in any group of animals. Thes
e results indicate that lithium acts on liver glycogen metabolism in vivo i
n at least two different ways: one related to changes in insulinemia, and t
he other related to the direct action of lithium on the activity of some ke
y enzymes of liver glucose metabolism. (C) 2000 Academic Press.